Bausch Health Co. Inc. (BHC) Reports Q1 Loss of $0.55/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Bausch Health Announces First-Quarter 2023 Results
May 4, 2023 7:01 AM EDTFirst-Quarter revenues of $1.94 billion, up 1% reported and 4% organic1Solid revenue growth across core products, led by Xifaxan with 7% reported growthMid- and late-stage product pipeline advancingBausch Health provides consolidated full-year guidance, and Bausch Health (excl. B+L) confirms 2023 guidance
LAVAL, QC / ACCESSWIRE / May 4, 2023 / Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its first-quarter 2023 financial... More
